App-Quantinova.ai

Efficacy, Optimal Duration and Safety of Adjunctive Cilostazol in Acute ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents; a Multicenter, Randomized, Open Label, Phase 4 Trial

Soohyung Park - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Clopidogrel bisulfate

Gene Guided Antiplatelet Therapy for Acute Coronary Syndrome: An Updated Meta-Analysis

Senthil S Balasubramanian - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Clopidogrel bisulfate

Bad Fall, Good Catch: Diagnosing a Rare Condition Presenting as Acute Coronary Syndrome

Leila Haghighat - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Local NET Burden is Associated With Biomarkers of Thrombosis and Cardiac Damage in Left Atrial Cardiopathy

Kimberly Martinod - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Bivalirudin versus Unfractioned Heparin in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention: Results at One Year

Yulong Li - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bivalirudin

Association of Antiphospholipid Antibodies With Venous Thromboembolism in COVID-19

Prerna Sharma - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Megakaryocytes Participating in Thrombosis Under Inflammatory Stress and Sepsis: Direct Pathological Evidence in Two Cases

Hua Zhang - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Innocuous Levels of Pulmonary Thrombosis Protect Against Inflammatory Lung Injury via Endothelial Arachidonate 15-Lipoxygenase and Hypoxia-Inducible Factor 1α

Colin E Evans - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Venous but Not Arterial Thrombus is Biologically Active: Cellular and Enzymatic Contributions

Matthew T Bender - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

JAK2V617F Red Blood Cells Promote Atherosclerosis and Thrombosis

Wenli Liu - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Erythropoietin

Development of the Preclinical Science Integration and Translation (PRESCIANT) Method and Application to the Apolipoprotein E Knockout Mouse Atherosclerosis Model

Megan M Shuey - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Angiotensin II

Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency

Huijuan Dou - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

CD14+ CD16++ Monocytes Predict Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction

Mohamed AboAly - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Prognostic Value of Body Composition for Predicting Venous Thromboembolism in Pediatric, Adolescent, and Young Adult Patients With Lymphoma

Nguyen K Tram - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Risk of Cardiovascular and All-Cause Mortality in Patients with Myeloproliferative Neoplasms Following Heart Failure Hospitalization

Orly Leiva - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Impact of Heart Failure on Prognosis in Cancer Patients (Kurume-CREO Study)

Nagisa Morikawa - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Impact of Diabetes on Percutaneous Coronary Intervention Outcomes in STEMI Patients: The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) Collaboration

Mark Y Wong - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A Common Variant Near the Fibrinogen Gamma Chain Gene is an Independent Risk Factor for Thrombosis After Congenital Heart Surgery

Evan T Mercer - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Fibrinogen (IV)

Transfusion Requirements and Outcomes of Adult Patients With Congenital Heart Disease Undergoing Cardiovascular Surgery

Puja Dutta - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Platelets Contribute to Disease Severity in Covid-19

Tessa Barrett - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts